4.17. Analysis.
Comparison 4 Fluvoxamine versus SNRIs, Outcome 17 Sensitivity analysis ‐ Response (acute phase) 7. Funding ‐ Excluding trials funded by the fluvoxamine marketing company.
Comparison 4 Fluvoxamine versus SNRIs, Outcome 17 Sensitivity analysis ‐ Response (acute phase) 7. Funding ‐ Excluding trials funded by the fluvoxamine marketing company.